Media Release

Ventana Medical Systems, Inc. honored as one of Arizona’s Most Admired Companies

Tucson, AZ, July 21, 2016– Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, has been recognized as one of Arizona’s Most Admired Companies for 2016 by AZ Business Magazine and BestCompaniesAZ.

Headquartered in Tucson, Arizona, Ventana is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Passionately pursuing a mission to improve the lives of all patients afflicted with cancer, the company’s 1,400 employees develop and manufacture more than 250 cancer tests with related instruments for the 14 million people globally diagnosed with cancer each year.¹

The culture of constant innovation at Ventana fuels its vision and commitment to advancing personalized healthcare, which links the most accurate diagnosis with the most targeted treatment for each patient.

Arizona’s Most Admired Companies recognizes excellence in workplace culture, leadership, innovation, social responsibility and customer opinion. For the third year, Ventana was selected as one of the state’s Most Admired Companies from more than 150 nominations.

“We are thrilled to again be recognized among Arizona’s Most Admired Companies as we carry out our quest to advance the standard of care for cancer patients,” said Ann Costello, President, Ventana Medical Systems, Inc. “At the heart of our innovation is our people, and I am proud of the work we do every day to guide the discovery, development and delivery of medical diagnostic solutions and cancer tests that are shaping the practice of medicine now and in the future.”

Among the company’s innovative cancer tests and related instruments approved by the U.S. Food & Drug Administration within the past year is the VENTANA HE 600 system, the industry’s first next-generation hematoxylin and eosin (H&E) staining instrument in more than a decade. H&E, the most widely used test in cancer diagnosis, is used to diagnose about 80 percent of cancer.

Ventana will be recognized Sept. 15 at the Most Admired Companies reception and dinner at the Chateau Luxe in Phoenix.

¹World Health Organization: Cancers figure among the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer related deaths in 2012.

About Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. (“VMSI”) (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA products are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive integrated staining, workflow management platforms and digital pathology solutions optimize laboratory efficiencies to help reduce errors, support diagnosis and enable informed treatment decisions by anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of companion diagnostics to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com.

Print:

Ventana Medical Systems, Inc.

Media Relations
Gabrielle Fimbres
Manager of External Communications
Phone: 520.222.4573
gabrielle.fimbres@roche.com

For Roche media inquiries, visit Roche media relations.